Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
4.100
+0.260 (6.77%)
At close: Jun 6, 2025, 4:00 PM
4.170
+0.070 (1.71%)
After-hours: Jun 6, 2025, 6:51 PM EDT
Health Catalyst Stock Forecast
Stock Price Forecast
According to 11 professional analysts, the 12-month price target for Health Catalyst stock ranges from a low of $4.00 to a high of $16. The average analyst price target of $8.00 forecasts a 95.12% increase in the stock price over the next year.
Price Target: $8.00 (+95.12%)
Analyst Consensus: Buy
* Price targets were last updated on May 8, 2025.
Analyst Ratings
The average analyst rating for Health Catalyst stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Hold | 2 | 3 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +119.51% | May 8, 2025 |
| Stifel | Stifel | Hold Maintains $5 → $5.5 | Hold | Maintains | $5 → $5.5 | +34.15% | May 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.5 | Strong Buy | Maintains | $7 → $6.5 | +58.54% | Apr 25, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +21.95% | Apr 16, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $6 → $4 | Buy → Hold | Downgrades | $6 → $4 | -2.44% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
341.01M
from 306.58M
Increased by 11.23%
Revenue Next Year
374.12M
from 341.01M
Increased by 9.71%
EPS This Year
0.30
from -1.15
EPS Next Year
0.42
from 0.30
Increased by 39.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 351.9M | 398.0M | 436.6M | |
| Avg | 341.0M | 374.1M | 414.7M | |
| Low | 323.5M | 345.6M | 390.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 14.8% | 16.7% | 16.7% | |
| Avg | 11.2% | 9.7% | 10.8% | |
| Low | 5.5% | 1.3% | 4.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.47 | 0.62 | 0.94 | |
| Avg | 0.30 | 0.42 | 0.76 | |
| Low | 0.21 | 0.29 | 0.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 106.5% | 124.6% | |
| Avg | - | 39.1% | 81.1% | |
| Low | - | -2.0% | 38.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.